Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Keros Therapeutics Inc KROS

Keros Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing novel therapeutics to treat a range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta (TGF-B), family of proteins. Its lead product candidate, KER-050, is being developed for the treatment of low blood cell counts, or... see more

Bullboard (NDAQ:KROS)

View:
User Avatar Image
(279)
•••
  • whytestocksX
Post by whytestockson Sep 03, 2024 10:47am

Keros Therapeutics Announces Update on Enrollment in the Pha

Breaking News: $KROS Keros Therapeutics Announces Update on Enrollment in the Phase 2 TROPOS TrialLEXINGTON, Mass., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros& ...more  
User Avatar Image
(279)
•••
  • whytestocksX
Post by whytestockson Aug 04, 2024 10:16pm

Long Term Trading Analysis for (KROS)

BREAKING NEWS: $KROS Long Term Trading Analysis for (KROS)2024-08-04 21:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities